We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at ...

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Tempus AI, Inc. (NASDAQ ... On February 3 rd, the company announced that it had completed its acquisition of Ambry Genetics, a genetic testing company that strives to improve health by ...

All thanks to three key catalysts. Tempus AI just acquired Ambry Genetics, a well-known leader in genetic testing, for $600 million, which includes $375 million in cash payments and $225 million ...

The acquisition also expands Tempus' database by integrating ... The deal also brings integration and execution risks. Ambry, a 25-year-old genetics testing firm, is expected to generate over ...

Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry Genetics ...

On Wednesday, TD Cowen reiterated its buy rating for Tempus AI’s shares, while increasing the price target to $74 after the company successfully closed its acquisition of Ambry Genetics, a deal that ...

Tempus AI (TEM) is soaring 13% today after investment bank ... Why TD Cowen Is Bullish on TEM TEM's acquisition of Ambry Genetics, which recently closed, should improve TEM's products and enable it to ...